| Detected | Trial | Change |
|---|---|---|
| 2026-08-02 | NCT05450770 Immunity to Yellow Fever in HIV-infected Patients 10 Years After a Primary Anti-yellow… |
overall status: Not Yet Recruiting → Unknown |
| 2026-07-28 | NCT06203132 DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People… |
date change Primary completion pushed: 2026-11 -> 2028-01 |
| 2026-07-28 | NCT06203132 DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People… |
date change Completion pushed: 2027-11 -> 2029-01 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05403047 | Efficacy of Tenofovir Disoproxil on Mother-to-child Transmission of HBV in Tokombéré… | Hepatitis B Virus - Chronic Active | Recruiting |
| NCT07098481 | Access to Hepatitis C Treatment in Cameroon: Comparison of a Simplified Test and Treat… | Hepatitis C Virus Infection | Not Yet Recruiting |
| Phase 3 | |||
| NCT05813964 | Efficacy, Acceptability and Safety of Event-driven HIV PrEP Using TAF/FTC in MSM in… | HIV/AIDS | Recruiting |
| NCT04145258 | Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous… | Tuberculous Meningitis | Recruiting |
| NCT06203132 | DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People… | HIV-1-infection | Recruiting |
| NCT06273943 | Impact of Long-acting Injectable Cabotegravir for HIV PrEP in MSM in France. | Prevention | Not Yet Recruiting |
| NCT06841614 | EBOla Post-Exposure Prophylaxis | Ebola Virus Disease | Not Yet Recruiting |
| NCT05597735 | Assessment of the Efficacy and Safety of Tecovirimat in Patients With Monkeypox Virus… | Monkeypox | Active, Not Recruiting |
| Phase 2 | |||
| NCT05300035 | Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1… | HIV/AIDS and Infections | Recruiting |
| NCT05590455 | Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis | Tuberculous Meningitis | Recruiting |
| NCT05587894 | OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized… | COVID-19 | Recruiting |
| NCT06338826 | Study Evaluating the Safety, in Terms of HBV Virological Control At 96 Weeks, of 2… | HIV Infections | Not Yet Recruiting |
| NCT07081763 | Immunotherapy With Baricitinib and Sirolimus, Alone and in Combination, for the Control… | HIV-1-infection | Not Yet Recruiting |
| NCT05202288 | Impact of Delay Between Administration of Inmazeb Administration and Vaccination by… | Ebola Virus Disease | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT06255626 | Safety and Immunogenicity of a Sub-unit Protein CD40.RBDv Bivalent COVID-19 Vaccine… | COVID-19 | Recruiting |
| NCT06821126 | Study Comparing Safety and Immunogenicity of Intranasal COVID-19 Vaccine and mRNA Booster… | Healthy | Recruiting |
| NCT07113106 | Dose Escalation Trial of CD40.Pan.CoV Vaccine, Adjuvanted or Not, as a Booster in Adult… | Healthy Volunteers | Active, Not Recruiting |
| Early Phase 1 | |||
| NCT07605520 | An Experimental Medicine Multicenter Trial to Evaluate the Safety and Immunogenicity of… | Healthy Adults | Recruiting |
| Not specified | |||
| NCT05655702 | DRug Use & Infections in ViEtnam: TuBerculosis Control | Tuberculosis | Recruiting |
| NCT04166266 | National Cohort of Patients Co-infected With Hepatitis B and Delta Viruses | Hepatitis D, Chronic | Recruiting |
| NCT06522256 | Identification of Molecular Signatures of High-risk Oncogenic HPV and Study of Their… | HPV Infection | Recruiting |
| NCT01520844 | the ANRS CO21 " Extreme " Cohort (CODEX) | HIV Infection | Recruiting |
| NCT06893757 | Prospective Cohort of People Starting Treatment for Tuberculosis Disease in France… | Tuberculosis | Recruiting |
| NCT05745168 | Pilot Implementation of HIV Self-testing Delivery in Private Pharmacies Combined to a… | HIV Infections | Not Yet Recruiting |
| NCT02043418 | Outcome at 5 Years of Early Treated HIV Infected Infants in the PEDIACAM Project | HIV | Active, Not Recruiting |